MYH11 and metastatic malignant neoplasm in the lymph nodes: By analyzing the clinicopathologic parameters of the patients, we observed that the poor expression of MYH11 also correlated with the tumor size, TNM stage, and lymph node metastasis of the patients (Table 3).